Johnson&Johnson Pharmaceutical Research&Development (J&JPRD), Medicinal Chemistry Department, campus de Maigremont BP615, 27106 Val de Reuil, France. pangibau@PRDFR.jnj.com
Abstract:
A series of pyrimidyl-5-hydroxamic acids was prepared for evaluation as inhibitors of histone deacetylase (HDAC). Amino-2-pyrimidinyl can be used as a linker to provide HDAC inhibitors of good enzymatic potency.